vs
Side-by-side financial comparison of LOGITECH INTERNATIONAL S.A. (LOGI) and Insulet Corporation (PODD). Click either name above to swap in a different company.
LOGITECH INTERNATIONAL S.A. is the larger business by last-quarter revenue ($1.4B vs $783.7M, roughly 1.8× Insulet Corporation). LOGITECH INTERNATIONAL S.A. runs the higher net margin — 17.7% vs 13.0%, a 4.7% gap on every dollar of revenue. On growth, Insulet Corporation posted the faster year-over-year revenue change (31.2% vs 6.1%). LOGITECH INTERNATIONAL S.A. produced more free cash flow last quarter ($465.6M vs $48.2M). Over the past eight quarters, Insulet Corporation's revenue compounded faster (33.2% CAGR vs 18.5%).
Logitech International S.A. is a Swiss multinational manufacturer of computer peripherals and software. Headquartered in Lausanne, Switzerland, the company has offices throughout Europe, Asia, Oceania, and the Americas. It is a component of the Swiss Market Index, and is listed on the Nasdaq.
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy . The device configuration may vary depending on design. A traditional pump includes:the pump a disposable reservoir for insulin a disposable infusion set, including a cannula for subcutaneous insertion and a tubing system to connect the insulin reservoir to the cannula.
LOGI vs PODD — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.4B | $783.7M |
| Net Profit | $251.0M | $101.6M |
| Gross Margin | 43.2% | 72.6% |
| Operating Margin | 20.1% | 18.7% |
| Net Margin | 17.7% | 13.0% |
| Revenue YoY | 6.1% | 31.2% |
| Net Profit YoY | 25.4% | 0.9% |
| EPS (diluted) | $1.69 | $1.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.4B | $783.7M | ||
| Q3 25 | $1.2B | $706.3M | ||
| Q2 25 | $1.1B | $649.1M | ||
| Q1 25 | $1.0B | $569.0M | ||
| Q4 24 | $1.3B | $597.5M | ||
| Q3 24 | $1.1B | $543.9M | ||
| Q2 24 | $1.1B | $488.5M | ||
| Q1 24 | $1.0B | $441.7M |
| Q4 25 | $251.0M | $101.6M | ||
| Q3 25 | $170.7M | $87.6M | ||
| Q2 25 | $146.0M | $22.5M | ||
| Q1 25 | $144.1M | $35.4M | ||
| Q4 24 | $200.1M | $100.7M | ||
| Q3 24 | $145.5M | $77.5M | ||
| Q2 24 | $141.8M | $188.6M | ||
| Q1 24 | $167.6M | $51.5M |
| Q4 25 | 43.2% | 72.6% | ||
| Q3 25 | 43.4% | 72.2% | ||
| Q2 25 | 41.7% | 69.7% | ||
| Q1 25 | 43.1% | 71.9% | ||
| Q4 24 | 42.9% | 72.1% | ||
| Q3 24 | 43.6% | 69.3% | ||
| Q2 24 | 42.8% | 67.7% | ||
| Q1 24 | 43.2% | 69.5% |
| Q4 25 | 20.1% | 18.7% | ||
| Q3 25 | 16.1% | 16.7% | ||
| Q2 25 | 14.1% | 18.7% | ||
| Q1 25 | 10.5% | 15.6% | ||
| Q4 24 | 17.5% | 18.3% | ||
| Q3 24 | 14.4% | 16.2% | ||
| Q2 24 | 14.1% | 11.2% | ||
| Q1 24 | 12.9% | 12.9% |
| Q4 25 | 17.7% | 13.0% | ||
| Q3 25 | 14.4% | 12.4% | ||
| Q2 25 | 12.7% | 3.5% | ||
| Q1 25 | 14.3% | 6.2% | ||
| Q4 24 | 14.9% | 16.9% | ||
| Q3 24 | 13.0% | 14.2% | ||
| Q2 24 | 13.0% | 38.6% | ||
| Q1 24 | 16.6% | 11.7% |
| Q4 25 | $1.69 | $1.42 | ||
| Q3 25 | $1.15 | $1.24 | ||
| Q2 25 | $0.98 | $0.32 | ||
| Q1 25 | $0.94 | $0.50 | ||
| Q4 24 | $1.32 | $1.38 | ||
| Q3 24 | $0.95 | $1.08 | ||
| Q2 24 | $0.92 | $2.59 | ||
| Q1 24 | $1.07 | $0.73 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.8B | — |
| Total DebtLower is stronger | — | $930.8M |
| Stockholders' EquityBook value | $2.3B | $1.5B |
| Total Assets | $4.1B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.61× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.8B | — | ||
| Q3 25 | $1.4B | — | ||
| Q2 25 | $1.5B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.5B | — | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.5B | — | ||
| Q1 24 | $1.5B | — |
| Q4 25 | — | $930.8M | ||
| Q3 25 | — | $934.9M | ||
| Q2 25 | — | $939.0M | ||
| Q1 25 | — | $1.6B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.4B | ||
| Q2 24 | — | $1.4B | ||
| Q1 24 | — | $1.4B |
| Q4 25 | $2.3B | $1.5B | ||
| Q3 25 | $2.1B | $1.4B | ||
| Q2 25 | $2.2B | $1.5B | ||
| Q1 25 | $2.1B | $1.3B | ||
| Q4 24 | $2.1B | $1.2B | ||
| Q3 24 | $2.1B | $1.1B | ||
| Q2 24 | $2.2B | $998.4M | ||
| Q1 24 | $2.2B | $790.7M |
| Q4 25 | $4.1B | $3.2B | ||
| Q3 25 | $3.7B | $3.0B | ||
| Q2 25 | $3.7B | $3.5B | ||
| Q1 25 | $3.5B | $3.5B | ||
| Q4 24 | $3.7B | $3.1B | ||
| Q3 24 | $3.6B | $3.0B | ||
| Q2 24 | $3.7B | $2.9B | ||
| Q1 24 | $3.6B | $2.6B |
| Q4 25 | — | 0.61× | ||
| Q3 25 | — | 0.68× | ||
| Q2 25 | — | 0.64× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | 1.07× | ||
| Q3 24 | — | 1.21× | ||
| Q2 24 | — | 1.36× | ||
| Q1 24 | — | 1.72× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $480.5M | $183.3M |
| Free Cash FlowOCF − Capex | $465.6M | $48.2M |
| FCF MarginFCF / Revenue | 32.8% | 6.2% |
| Capex IntensityCapex / Revenue | 1.0% | 17.2% |
| Cash ConversionOCF / Net Profit | 1.91× | 1.80× |
| TTM Free Cash FlowTrailing 4 quarters | $903.6M | $377.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $480.5M | $183.3M | ||
| Q3 25 | $228.8M | $125.7M | ||
| Q2 25 | $125.0M | $196.5M | ||
| Q1 25 | $129.7M | $63.8M | ||
| Q4 24 | $370.9M | $147.7M | ||
| Q3 24 | $166.0M | $98.5M | ||
| Q2 24 | $176.0M | $96.5M | ||
| Q1 24 | $239.1M | $87.6M |
| Q4 25 | $465.6M | $48.2M | ||
| Q3 25 | $212.3M | $100.1M | ||
| Q2 25 | $108.8M | $177.9M | ||
| Q1 25 | $116.9M | $51.5M | ||
| Q4 24 | $356.6M | $94.1M | ||
| Q3 24 | $151.5M | $71.8M | ||
| Q2 24 | $161.4M | $74.0M | ||
| Q1 24 | $228.8M | $65.5M |
| Q4 25 | 32.8% | 6.2% | ||
| Q3 25 | 17.9% | 14.2% | ||
| Q2 25 | 9.5% | 27.4% | ||
| Q1 25 | 11.6% | 9.1% | ||
| Q4 24 | 26.6% | 15.7% | ||
| Q3 24 | 13.6% | 13.2% | ||
| Q2 24 | 14.8% | 15.1% | ||
| Q1 24 | 22.6% | 14.8% |
| Q4 25 | 1.0% | 17.2% | ||
| Q3 25 | 1.4% | 3.6% | ||
| Q2 25 | 1.4% | 2.9% | ||
| Q1 25 | 1.3% | 2.2% | ||
| Q4 24 | 1.1% | 9.0% | ||
| Q3 24 | 1.3% | 4.9% | ||
| Q2 24 | 1.3% | 4.6% | ||
| Q1 24 | 1.0% | 5.0% |
| Q4 25 | 1.91× | 1.80× | ||
| Q3 25 | 1.34× | 1.43× | ||
| Q2 25 | 0.86× | 8.73× | ||
| Q1 25 | 0.90× | 1.80× | ||
| Q4 24 | 1.85× | 1.47× | ||
| Q3 24 | 1.14× | 1.27× | ||
| Q2 24 | 1.24× | 0.51× | ||
| Q1 24 | 1.43× | 1.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LOGI
| Retail Gaming | $482.7M | 34% |
| Retail Keyboards Desktops | $254.6M | 18% |
| Retail Pointing Devices | $241.2M | 17% |
| Retail Video Collaboration | $193.3M | 14% |
| Retail Tablet And Other Accessories | $93.6M | 7% |
| Retail Webcams | $82.3M | 6% |
| Retail Headsets | $45.9M | 3% |
| Other Retail Products | $28.0M | 2% |
PODD
| U.S.Omnipod | $567.8M | 72% |
| International Omnipod | $214.0M | 27% |
| Drug Delivery | $1.9M | 0% |
